The potential of blood group genotyping for transfusion medicine practice
Paid access
|Mar 2020References
- Westhoff CM. Molecular testing for transfusion medicine. Curr Opin Hematol 2006;13:471–5.
- Tournamille C, Colin Y, Cartron J-P, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995; 10:224–8.
- Storry JR, Reid ME, Fetics S, Huang C. Mutations in the GYPB exon 5 drive the S-s-U+var phenotype in persons of African descent: implications for transfusion. Transfusion 2003;43:1738–47.
- Lomas-Francis C, DePalma H. 2007 Rock Øyen Symposium: DNA-based assays for patient testing: their application, interpretation, and correlation of results. Immunohematology 2008; 24:180–90.
- Avent ND, Martinez A, Flegel WA, et al. The BloodGen project: toward mass-scale comprehensive genotyping of blood donors in the European Union and beyond. Transfusion 2007; 47(Suppl):40–6S.
- Beiboer SH, Wieringa-Jelsma T, Maaskant-Van Wijk PA, et al. Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridization. Transfusion 2005;45:667–79.
- Hashmi G, Shariff T, Seul M, et al. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 2005;45:680–8.
- Montpetit A, Phillips MS, Mongrain I, Lemieux R, St-Louis M. High-throughput molecular profiling of blood donors for minor red blood cell and platelet antigens. Transfusion 2006;46:841–8.
- Strauss D, Reid LM. 2007 Rock Øyen Symposium: Value of DNA-based assays for donor screening and regulatory issues. Immunohematology 2008; 24:175–9.
- Higgins JM, Sloan SR. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 2008;112:2546–53.
- Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990;76:1431–7.
- Daniels G, Flegel WA, Fletcher A, et al. International Society of Blood Transfusion Committee on Terminology for Red Cell Surface Antigens: Cape Town report. Vox Sang 2007; 92:250–3.
- Smith-Whitley KS. Pediatric transfusion therapy. 1st ed. Bethesda: AABB Press, 2002.
- Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood 1993; 81:1109–23.
- Ness PM. To match or not to match: the question for chronically transfused patients with sickle cell anemia. Transfusion 1994;34:558–60.
- Tahhan HR, Holbrook CT, Braddy LR, Brewer LD, Christie JD. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994;34:562–9.
- Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001; 41:1086–92.
- Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 1987;27:94–8.
- Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002;42:37–43.
- Westhoff CM. Rh complexities: serology and DNA genotyping. Transfusion 2007;47 (Suppl):17–22S.
- Hemker MB, Ligthart PC, Berger L, van Rhenen DJ, van der Schoot CE, Maaskant-van Wijk PA. DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African Blacks. Blood 1999;94:4337–42.
- Daniels GL, Faas BH, Green CA, et al. The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis. Transfusion 1998;38:951–8.
- Noizat-Pirenne F, Lee K, Pennec PY, et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood 2002;100:4223–31.
- Vege S, Westhoff CM. Molecular characterization of GYPB and RH in donors in the American Rare Donor Program. Immunohematology 2006;22: 143–7.
- Hashmi G, Mezokh N, Vege S, Westhoff CM. Successful discrimination of altered e antigens by DNA analysis with a RHCE BeadChip™ (abstract). Transfusion 2007.
- Schonewille H, van de Watering LM, Brand A. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 2006;46:630–5.
- Lacey PA, Caskey CR, Werner DJ, Moulds JJ. Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother. Transfusion 1983;23:91–4.
- Westhoff CM. Review: the Rh blood group D antigen…dominant, diverse, and difficult. Immunohematology 2005;21:155–63.
- Caine ME, Mueller-Heubach E. Kell sensitization in pregnancy. Am J Obstet Gynecol 1986; 154:85–90.
- Klein HG, Anstee DJ. Blood transfusion in clinical medicine. 11th ed. Oxford, UK: Blackwell, 2005.
- Hackney DN, Knudtson EJ, Rossi KQ, Krugh D, O’Shaughnessy RW. Management of pregnancies complicated by anti-c isoimmunization. Obstet Gynecol 2004;103:24–30.
DOI: https://doi.org/10.21307/immunohematology-2019-297 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 190 - 195
Published on: Mar 25, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2020 C.M. Westhoff, published by American National Red Cross
This work is licensed under the Creative Commons License.